ETF异动 | 南方恒生生科(03174)涨超5% 创新药龙头业绩集中爆发全球产业链景气度维持高位

智通财经08-07

智通财经APP获悉，南方恒生生科(03174)涨超5%，截至发稿，涨5.4%，报3.628港元，成交额723.74万港元。据悉，南方恒生生科跟踪恒生生物科技指数，覆盖制药、生物技术、CRO(医药研发外包) 等细分领域的龙头企业，前五大持仓包括信达生物(01801)、百济神州(06160)、药明生物(02269)、药明康德(02359)及康方生物(09926)。消息面上，近日，多家创新药龙头企业...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohunote.com/m/news/2657697002?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-08-07 14:56","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2657697002","market":"sh","top_or_hot":-1,"title":"ETF异动 | 南方恒生生科(03174)涨超5% 创新药龙头业绩集中爆发 全球产业链景气度维持高位","media":"智通财经","content":"<div>\n<p>智通财经APP获悉，南方恒生生科(03174)涨超5%，截至发稿，涨5.4%，报3.628港元，成交额723.74万港元。据悉，南方恒生生科跟踪恒生生物科技指数，覆盖制药、生物技术、CRO(医药研发外包) 等细分领域的龙头企业，前五大持仓包括信达生物(01801)、百济神州(06160)、药明生物(02269)、药明康德(02359)及康方生物(09926)。消息面上，近日，多家创新药龙头企业...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1477234.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ETF异动 | 南方恒生生科(03174)涨超5% 创新药龙头业绩集中爆发 全球产业链景气度维持高位</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nETF异动 | 南方恒生生科(03174)涨超5% 创新药龙头业绩集中爆发 全球产业链景气度维持高位\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-08-07 14:56 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1477234.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP获悉，南方恒生生科(03174)涨超5%，截至发稿，涨5.4%，报3.628港元，成交额723.74万港元。据悉，南方恒生生科跟踪恒生生物科技指数，覆盖制药、生物技术、CRO(医药研发外包) 等细分领域的龙头企业，前五大持仓包括信达生物(01801)、百济神州(06160)、药明生物(02269)、药明康德(02359)及康方生物(09926)。消息面上，近日，多家创新药龙头企业...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1477234.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU1719994722.HKD","symbol_name":"NINETY ONE GSF ALL CHINA EQUITY \"A\" (HKD) ACC","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1477234.html","article_id":"2657697002","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2657697002","pubTimestamp":1786085810,"columns":[],"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP获悉，南方恒生生科涨超5%，截至发稿，涨5.4%，报3.628港元，成交额723.74万港元。百济神州上半年归母净利润达32.71亿元，同比增长627.1%，并上调全年营收预期。信达生物上半年产品收入同比增长超过55%，该公司综合产品线保持强劲增长。兴业证券表示，全球创新药及产业链景气度维持高位，多家海外MNC与CXO披露中报盈喜并上调2026年全年指引，验证全球创新药研发投入与产业链需求仍处于较高景气区间。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"159992":"创新药","LU1719994722.HKD":"NINETY ONE GSF ALL CHINA EQUITY \"A\" (HKD) ACC","LU0348825331.USD":"ALLIANZ CHINA EQUITY \"A\" (USD) INC","LNGR":"Global X Longevity Thematic ETF","LU0320764599.SGD":"FTIF - Templeton China A Acc SGD","BK1583":"高瓴概念","IE00B0JY6N72.USD":"PINEBRIDGE GLOBAL EMERGING MARKETS FOCUS EQUITY \"A\" (USD) ACC","FDN":"First Trust Dow Jones Internet I","LU1770034418.SGD":"ALL CHINA EQUITY \"A\" (SGDHDG) ACC","LU0708995583.HKD":"TEMPLETON CHINA \"A\" (HKD) ACC","BK1521":"挪威政府全球养老基金持仓","LU2125910500.SGD":"Natixis WCM Global Emerging Markets Equity H-R/A SGD","LU3063872942.SGD":"FULLERTON LUX FUNDS ASIA EQUITIES \"I\" (SGD) ACC","LU2476274720.SGD":"ALLIANZ CHINA FUTURE TECHNOLOGIES \"AT\" (SGDHDG) ACC","LU1242518857.USD":"FULLERTON LUX FUNDS - ASIA ABSOLUTE ALPHA \"I\" (USD) ACC","LU0348766576.USD":"ALLIANZ LITTLE DRAGONS \"A\" (USD) INC","IBBQ":"Invesco Nasdaq Biotechnology ETF","06978":"永泰生物-B","LU1046422090.SGD":"Fidelity Pacific A-SGD","09926":"康方生物","06160":"百济神州","LU0502904849.HKD":"FIDELITY FUNDS  CHINA INNOVATION \"A\" (HKD) ACC","LU0348767384.USD":"ALLIANZLITTLE DRAGONS \"A\" (USD) ACC","BK4550":"红杉资本持仓","BK1500":"做空集合股","BK4588":"碎股","02269":"药明生物","02359":"药明康德","03174":"南方恒生生科","LU2399975544.HKD":"ALLIANZ ALL CHINA EQUITY \"AT\" (HKD) ACC","LU2097828474.EUR":"AZ EQUITY CHINA \"A\" (EUR) ACC A","KURE":"KraneShares MSCI All China Health Care Index ETF","LU0823426480.USD":"法巴中国股票经典Dis","MEDX":"HORIZON KINETICS MEDICAL ETF","LU0348827113.USD":"ALLIANZ RCM CHINA \"AT\" ACC","BK4585":"ETF&股票定投概念","BK1161":"生物科技","LU1251922891.USD":"NINETY ONE GSF ALL CHINA EQUITY \"A\" (USD) ACC","SG9999002562.SGD":"LionGlobal Asia Pacific SGD","LU0455707207.USD":"FIDELITY FUNDS  CHINA INNOVATION \"A\" (USD) INC","LU0051755006.USD":"摩根大通中国A (dist)","LU0516422366.SGD":"Fullerton Lux Funds - Asia Focus Equities A Acc SGD","LU0540923850.HKD":"ALLIANZ HONG KONG EQUITY \"A\" (HKD) INC","LU1720050803.USD":"安联全方位中国股票基金","LU0572944931.SGD":"Janus Henderson Horizon China Opportunities A2 SGD","LU0456827905.SGD":"JPMorgan Funds - China A (acc) SGD","01801":"信达生物","LU0181495838.USD":"施罗德新兴亚洲A Acc","LU1961090484.USD":"ALLIANZ ALL CHINA EQUITY \"A\" (USD) INC","BK1587":"次新股"},"translate_title":"ETF Changes | Southern Hang Seng Biotech (03174) rose by more than 5%, and the performance of the leading innovative drug exploded. The prosperity of the global industrial chain remained high","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"159992":1.5,"FDN":1.5,"01801":0.9,"09926":0.9,"MEDX":1.5,"02359":0.9,"02269":0.9,"KURE":0.6,"03174":1.5,"IBBQ":1.5,"06978":1.5,"06160":0.9,"LNGR":1.5},"content_text":"智通财经APP获悉，南方恒生生科(03174)涨超5%，截至发稿，涨5.4%，报3.628港元，成交额723.74万港元。据悉，南方恒生生科跟踪恒生生物科技指数，覆盖制药、生物技术、CRO(医药研发外包) 等细分领域的龙头企业，前五大持仓包括信达生物(01801)、百济神州(06160)、药明生物(02269)、药明康德(02359)及康方生物(09926)。消息面上，近日，多家创新药龙头企业2026年中期业绩迎来爆发，其中，药明康德第二季度营收突破164亿元，单季营收与利润双双创下历史新高；药明康德表示，上半年业绩强劲得益于多个客户产品的更大成功及CRDMO模式，同时公司全面上调全年指引。百济神州上半年归母净利润达32.71亿元，同比增长627.1%，并上调全年营收预期。信达生物上半年产品收入同比增长超过55%，该公司综合产品线保持强劲增长。兴业证券表示，全球创新药及产业链景气度维持高位，多家海外MNC与CXO披露中报盈喜并上调2026年全年指引，验证全球创新药研发投入与产业链需求仍处于较高景气区间。中信证券则认为，医药板块内部呈现K型分化，创新药、CXO等科技属性较强的细分领域有望率先走出调整，建议关注研发管线丰富、商业化能力突出的龙头企业。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2657697002","isCrawlerRequest":true}

ETF异动 | 南方恒生生科(03174)涨超5% 创新药龙头业绩集中爆发 全球产业链景气度维持高位

精彩评论

ETF异动 | 南方恒生生科(03174)涨超5% 创新药龙头业绩集中爆发全球产业链景气度维持高位